# OnCo record nct02488967 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02488967/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02488967", "NCT02488967" ;
  schema:name "Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer"@en ;
  schema:description "A phase 3 trial of carboplatin, cyclophosphamide, doxorubicin and paclitaxel / nab-paclitaxel in triple-negative breast cancer, run by NRG Oncology, active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02488967/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02488967> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "tnbc-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/> .